再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ZLAB 再鼎医药

已收盘 04-18 16:00:00 EDT

14.22

+0.50

+3.64%

盘后14.22

+0.000.00%

16:36 EDT

最高14.23	最低13.48	成交量69.47万
今开13.62	昨收13.72	日振幅5.47%
总市值14.04亿	流通市值12.62亿	总股本9,872万
成交额977.07万	换手率0.78%	流通股本8,878万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ZLAB","market":"US","secType":"STK","nameCN":"再鼎医药","latestPrice":14.22,"timestamp":1713470400000,"preClose":13.72,"halted":0,"volume":694734,"hourTrading":{"tag":"盘后","latestPrice":14.22,"preClose":14.22,"latestTime":"16:36 EDT","volume":8083,"amount":114926.55,"timestamp":1713472590101},"delay":0,"floatShares":88780449,"shares":98717523,"eps":-3.462562,"marketStatus":"已收盘","marketStatusCode":5,"change":0.5,"latestTime":"04-18 16:00:00 EDT","open":13.62,"high":14.23,"low":13.48,"amount":9770673.671004,"amplitude":0.054665,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.462562,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1713513600000},"adr":1,"listingDate":1505880000000,"adjPreClose":13.72,"adrRate":10,"postHourTrading":{"tag":"盘后","latestPrice":14.22,"preClose":14.22,"latestTime":"16:36 EDT","volume":8083,"amount":114926.55,"timestamp":1713472590101},"volumeRatio":1.585453},"requestUrl":"/m/hq/s/ZLAB","defaultTab":"news","newsList":[{"id":"2428583187","title":"再鼎医药(09688)股价下跌5.179%，现价港币$10.62","url":"https://stock-news.laohu8.com/highlight/detail?id=2428583187","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2428583187?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:45","pubTimestamp":1713404700,"startTime":"0","endTime":"0","summary":"[下跌股]再鼎医药(09688) 股价在上午09:45比前收市价下跌5.179%，现股价为港币$10.62。至目前为止，今日最高价为$10.92，而最低价为$10.62。总成交量为35.67万股，总成交金额为港币$383.871万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126135515084_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD240418247/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428434295","title":"再鼎医药盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428434295","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428434295?lang=zh_cn&edition=full","pubTime":"2024-04-17 22:35","pubTimestamp":1713364503,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日22时35分，再鼎医药股票出现异动，股价大幅下跌5.03%。截至发稿，该股报13.70美元/股，成交量10.2034万股，换手率0.10%，振幅5.34%。再鼎医药股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Vanda Pharmaceuticals Inc.涨幅较大，Palisade Bio, Inc.、Longeveron Inc.、Jaguar Health, Inc.较为活跃，换手率分别为128.40%、35.65%、32.21%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Revolution Medicines Inc C/Wts 17/12/2026 、Dare Bioscience, Inc.，振幅分别为80.94%、40.00%、38.52%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041722350387e8165f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041722350387e8165f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427049684","title":"再鼎医药(09688)股价下跌5.026%，现价港币$10.96","url":"https://stock-news.laohu8.com/highlight/detail?id=2427049684","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427049684?lang=zh_cn&edition=full","pubTime":"2024-04-15 14:15","pubTimestamp":1713161700,"startTime":"0","endTime":"0","summary":"[下跌股]再鼎医药(09688) 股价在下午02:15比前收市价下跌5.026%，现股价为港币$10.96。至目前为止，今日最高价为$11.46，而最低价为$10.96。总成交量为288.425万股，总成交金额为港币$3.207千万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133703138_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404152321/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427875403","title":"再鼎医药下跌5.03%，报14.26美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427875403","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427875403?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:24","pubTimestamp":1712949851,"startTime":"0","endTime":"0","summary":"4月13日，再鼎医药(ZLAB)盘中下跌5.03%，截至03:24，报14.26美元/股，成交366.71万美元。财务数据显示，截至2023年12月31日，再鼎医药收入总额2.67亿美元，同比增长24.03%；归母净利润-3.35亿美元，同比增长24.51%。大事提醒：5月14日，再鼎医药将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/13032440224654.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2427549467","title":"再鼎医药盘中异动 股价大跌5.00%报14.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2427549467","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427549467?lang=zh_cn&edition=full","pubTime":"2024-04-13 03:23","pubTimestamp":1712949809,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日03时23分，再鼎医药股票出现波动，股价大幅跳水5.00%。截至发稿，该股报14.26美元/股，成交量24.8997万股，换手率0.25%，振幅4.53%。再鼎医药股票所在的生物技术行业中，整体跌幅为1.76%。其相关个股中，Paxmedica, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Q32 Bio Inc.涨幅较大，Allarity Therapeutics, Inc.、Paxmedica, Inc.、Aptevo Therapeutics Inc.较为活跃，换手率分别为3755.15%、1493.34%、108.72%，振幅较大的相关个股有Paxmedica, Inc.、Allarity Therapeutics, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为93.97%、74.01%、63.12%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130323297a527bc1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130323297a527bc1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426441066","title":"再鼎医药下跌5.43%，报15.15美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2426441066","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2426441066?lang=zh_cn&edition=full","pubTime":"2024-04-11 00:38","pubTimestamp":1712767096,"startTime":"0","endTime":"0","summary":"4月11日，再鼎医药(ZLAB)盘中下跌5.43%，截至00:38，报15.15美元/股，成交316.13万美元。财务数据显示，截至2023年12月31日，再鼎医药收入总额2.67亿美元，同比增长24.03%；归母净利润-3.35亿美元，同比增长24.51%。大事提醒：5月14日，再鼎医药将披露2024财年一季报。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/11003840189135.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2426220410","title":"再鼎医药盘中异动 股价大跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2426220410","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426220410?lang=zh_cn&edition=full","pubTime":"2024-04-11 00:38","pubTimestamp":1712767086,"startTime":"0","endTime":"0","summary":"北京时间2024年04月11日00时38分，再鼎医药股票出现波动，股价快速下挫5.11%。截至发稿，该股报15.20美元/股，成交量19.2889万股，换手率0.19%，振幅4.62%。再鼎医药股票所在的生物技术行业中，整体跌幅为1.16%。其相关个股中，Adial Pharmaceuticals, Inc、Jaguar Health, Inc.、Orgenesis Inc.涨幅较大，Adial Pharmaceuticals, Inc、Silo Pharma, Inc.、Jaguar Health, Inc.较为活跃，换手率分别为1920.27%、76.55%、51.93%，振幅较大的相关个股有Adial Pharmaceuticals, Inc、Orgenesis Inc.、Nutriband Inc C/Wts ，振幅分别为87.61%、74.23%、52.44%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411003806861e4b45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240411003806861e4b45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426481838","title":"美银证券降再鼎医药目标价至16.04元，评级“买入”","url":"https://stock-news.laohu8.com/highlight/detail?id=2426481838","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426481838?lang=zh_cn&edition=full","pubTime":"2024-04-10 11:49","pubTimestamp":1712720940,"startTime":"0","endTime":"0","summary":"美银证券发表报告指出，再鼎医药的尼拉帕利、瑞派替尼、甲苯磺酸奥马环素及艾加莫德于2月份的销售分别为5,750万、350万、1,100万及290万元人民币，按年各增长20.8%、2.98倍、6.2倍及不适用，按月则跌18.8%、9.4%、30.6%及0.6%。因此，该行下调对尼拉帕利长期收入预测，对再鼎医药目标价由19.92元下调至16.04元，重申“买入”评级，认为公司商业化进展顺利。沽空资料截至 2024-04-09 16:25。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20200925164734831_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20200925164734831_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1341252/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2425356458","title":"再鼎医药上涨2.03%，报15.76美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425356458","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425356458?lang=zh_cn&edition=full","pubTime":"2024-04-05 22:47","pubTimestamp":1712328448,"startTime":"0","endTime":"0","summary":"4月5日，再鼎医药(ZLAB)盘中上涨2.03%，截至22:47，报15.76美元/股，成交114.09万美元。财务数据显示，截至2023年12月31日，再鼎医药收入总额2.67亿美元，同比增长24.03%；归母净利润-3.35亿美元，同比增长24.51%。大事提醒：5月14日，再鼎医药将披露2024财年一季报。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/05224740132286.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425306157","title":"再鼎医药(09688)下跌5.14%，报11.82元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2425306157","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2425306157?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:43","pubTimestamp":1712284990,"startTime":"0","endTime":"0","summary":"4月5日，再鼎医药(09688)盘中下跌5.14%，截至10:43，报11.82元/股，成交1099.33万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2023年年报，再鼎医药营业总收入18.89亿元、净利润-23.7亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/05104340128870.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2425717308","title":"再鼎医药(09688)股价下跌5.136%，现价港币$11.82","url":"https://stock-news.laohu8.com/highlight/detail?id=2425717308","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2425717308?lang=zh_cn&edition=full","pubTime":"2024-04-05 09:59","pubTimestamp":1712282340,"startTime":"0","endTime":"0","summary":"[下跌股]再鼎医药(09688) 股价在上午09:59比前收市价下跌5.136%，现股价为港币$11.82。至目前为止，今日最高价为$12.5，而最低价为$11.82。总成交量为53.433万股，总成交金额为港币$638.518万。","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404051242/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2425376293","title":"再鼎医药(09688)授出可认购合共198.15万股的购股权及139.18万股受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2425376293","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2425376293?lang=zh_cn&edition=full","pubTime":"2024-04-05 08:13","pubTimestamp":1712275995,"startTime":"0","endTime":"0","summary":"再鼎医药(09688)发布公告，(i)于2024年4月1日(美国东部时间)，公司根...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_20.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_20.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1098766.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424835935","title":"再鼎医药(09688)下跌5.07%，报12.36元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424835935","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424835935?lang=zh_cn&edition=full","pubTime":"2024-04-03 09:58","pubTimestamp":1712109481,"startTime":"0","endTime":"0","summary":"4月3日，再鼎医药(09688)盘中下跌5.07%，截至09:58，报12.36元/股，成交441.49万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2023年年报，再鼎医药营业总收入18.89亿元、净利润-23.7亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/03095840108504.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424838354","title":"南向资金4月2日净买入再鼎医药6.15万股 连续5日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2424838354","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424838354?lang=zh_cn&edition=full","pubTime":"2024-04-03 09:31","pubTimestamp":1712107877,"startTime":"0","endTime":"0","summary":"4月2日, 南向资金增持再鼎医药6.15万股，连续5日增持。截止当日收盘，港股通共持有再鼎医药8480.11万股，占流通股8.54%。港股通增持金额前五个股分别为腾讯控股、中国银行、小米集团-W、建设银行、中国移动。再鼎医药近5个交易日上涨2.36%，港股通累计增持113.36万股；近20个交易日下跌19.33%，港股通累计增持933.53万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030943148aeb0a5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404030943148aeb0a5a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424404725","title":"再鼎医药盘中异动 早盘股价大跌5.17%报15.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2424404725","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424404725?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:48","pubTimestamp":1712069307,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时48分，再鼎医药股票出现波动，股价快速下跌5.17%。截至发稿，该股报15.86美元/股，成交量7.8139万股，换手率0.08%，振幅4.19%。再鼎医药股票所在的生物技术行业中，整体跌幅为1.68%。其相关个股中，Moolec Science Sa C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Aditxt, Inc.、Avalo Therapeutics, Inc.、Ibio, Inc.较为活跃，换手率分别为795.28%、31.52%、25.12%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Aditxt, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为104.31%、58.18%、57.38%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402224828861e307b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402224828861e307b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424726643","title":"再鼎医药上涨2.06%，报16.35美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2424726643","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2424726643?lang=zh_cn&edition=full","pubTime":"2024-04-02 01:06","pubTimestamp":1711991190,"startTime":"0","endTime":"0","summary":"4月2日，再鼎医药(ZLAB)盘中上涨2.06%，截至01:06，报16.35美元/股，成交539.58万美元。财务数据显示，截至2023年12月31日，再鼎医药收入总额2.67亿美元，同比增长24.03%；归母净利润-3.35亿美元，同比增长24.51%。大事提醒：5月14日，再鼎医药将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/04/02010640084537.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2424714336","title":"BUZZ-肺癌药物在晚期试验中达到主要目标后，Zai Lab业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2424714336","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424714336?lang=zh_cn&edition=full","pubTime":"2024-04-01 21:00","pubTimestamp":1711976413,"startTime":"0","endTime":"0","summary":"    4月1日 - ** 在美国上市的中国制药商Zai Lab Ltd  盘前股价大涨3.3%至16.55美元。** ZLab的合作伙伴百时美施贵宝  周四晚些时候表示，其药物 KRAZATI在一项针对突变非小细胞肺癌 的晚期研究中达到了主要目标。** 该药物还达到了研究的一个关键次要目标 ** ZLAB预计将于今年 向中国医药产品协会提交KRAZATI的新药申请，作为该适应症 的二线或后线治疗药物。** BMY将完成对现有数据的全面评估 ，并与卫生部门讨论评估结果** 截至周四收盘，ZLAB 的美 股累计下跌 41.4","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2422907063","title":"再鼎医药(09688)上涨5.12%，报13.14元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422907063","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422907063?lang=zh_cn&edition=full","pubTime":"2024-03-28 10:51","pubTimestamp":1711594281,"startTime":"0","endTime":"0","summary":"3月28日，再鼎医药(09688)盘中上涨5.12%，截至10:51，报13.14元/股，成交1293.81万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2023年年报，再鼎医药营业总收入18.89亿元、净利润-23.7亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/28105140030725.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2422626782","title":"再鼎医药下跌2.03%，报15.92美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2422626782","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2422626782?lang=zh_cn&edition=full","pubTime":"2024-03-27 03:29","pubTimestamp":1711481377,"startTime":"0","endTime":"0","summary":"3月27日，再鼎医药(ZLAB)盘中下跌2.03%，截至03:29，报15.92美元/股，成交901.27万美元。财务数据显示，截至2023年12月31日，再鼎医药收入总额2.67亿美元，同比增长24.03%；归母净利润-3.35亿美元，同比增长24.51%。大事提醒：5月14日，再鼎医药将披露2024财年一季报。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/03/27032940005260.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2421839434","title":"再鼎医药(09688)下跌5.07%，报12.74元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2421839434","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2421839434?lang=zh_cn&edition=full","pubTime":"2024-03-22 11:55","pubTimestamp":1711079708,"startTime":"0","endTime":"0","summary":"3月22日，再鼎医药(09688)盘中下跌5.07%，截至11:55，报12.74元/股，成交2509.86万元。再鼎医药有限公司主要业务是研发和销售针对肿瘤、自身免疫性疾病、感染性疾病和中枢神经系统疾病的创新药物，以满足全球患者的医疗需求。关键经营数据方面，公司以其强大的研发能力和全球化运营策略，致力于成为全球领先的生物制药公司。截至2023年年报，再鼎医药营业总收入18.89亿元、净利润-23.7亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/03/22115539952493.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.zailaboratory.com","stockEarnings":[{"period":"1week","weight":-0.1091},{"period":"1month","weight":-0.2412},{"period":"3month","weight":-0.4177},{"period":"6month","weight":-0.4262},{"period":"1year","weight":-0.6419},{"period":"ytd","weight":-0.498}],"compareEarnings":[{"period":"1week","weight":-0.0264},{"period":"1month","weight":-0.024},{"period":"3month","weight":0.0505},{"period":"6month","weight":0.1884},{"period":"1year","weight":0.2084},{"period":"ytd","weight":0.0531}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Zai Lab Ltd是一家主要从事生物制药的控股公司该公司致力于发现或许可、开发和商业化专有疗法，以解决中国市场中大量未满足医疗需求的领域，包括肿瘤学、自身免疫和传染病。该公司拥有从发现阶段到临床项目后期的一系列专利候选药物。其中包括Niraparib（ZL-2306）、ZL-2103和ZL-1101等。","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.113311},{"month":2,"riseRate":0.428571,"avgChangeRate":-0.022208},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.101183},{"month":4,"riseRate":0.428571,"avgChangeRate":0.008329},{"month":5,"riseRate":0.5,"avgChangeRate":0.025011},{"month":6,"riseRate":0.5,"avgChangeRate":0.078087},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.023267},{"month":8,"riseRate":0.666667,"avgChangeRate":0.013621},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.113197},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.064295},{"month":11,"riseRate":0.714286,"avgChangeRate":0.168146},{"month":12,"riseRate":0.571429,"avgChangeRate":-0.005362}],"exchange":"NASDAQ","name":"再鼎医药","nameEN":"Zai Lab Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供再鼎医药(ZLAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"再鼎医药,ZLAB,再鼎医药股票,再鼎医药股票老虎,再鼎医药股票老虎国际,再鼎医药行情,再鼎医药股票行情,再鼎医药股价,再鼎医药股市,再鼎医药股票价格,再鼎医药股票交易,再鼎医药股票购买,再鼎医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"再鼎医药(ZLAB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供再鼎医药(ZLAB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}